Prostate Cancer Stem Cell

Prostate cancer is now a common disease in men over 50 years of age. Medical therapies for prostate cancer are based on discoveries from the mid-twentieth century, and in the long term are rarely curative. Most treatments are directed towards an androgen receptor-expressing, highly proliferative target cell, which does indeed form the vast majority of cells in a prostate tumour. However, by invoking the existence of a cancer stem cell which, like normal epithelial stem cells in the prostate, does not express androgen receptor and is relatively quiescent, the observed resistance to most medical therapies can be explained. The phenotype of the prostate cancer stem cells is that of a basal cell and cultures derived from cancers, but not benign tissues, express a range of prostate cancer-associated RNAs.

  • Prostate Cancer Stem Cell and Its Complications
  • Prostatitis
  • Current Research on Prostate Cancer Stem Cell

Are you interested in

Mail us at

Drop us an email for Program enquiry
cancerstemcells@alliedconferences.org
Sponsors/Exhibiting/Advertising
cancerstemcells@alliedconference.com
General Queries
cancerstemcells@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy


Copyright © 2017-2018 Allied Academies, All Rights Reserved.